Benjamin F. Edwards & Company’s Pediatrix Medical MD Stock Holding History

Benjamin F. Edwards & Company’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,773	Closed	-$40K	–	1920
2019 Q3	$40K	Buy	1,773 +638	+56%	+$14.5K	﹤0.01%	994
2019 Q2	$29K	Hold	1,135	–	–	﹤0.01%	1069
2019 Q1	$31K	Buy	1,135 +314	+38%	+$10.5K	﹤0.01%	1007
2018 Q4	$27K	Buy	821 +186	+29%	+$7.48K	﹤0.01%	1009
2018 Q3	$30K	Buy	635 +135	+27%	+$6.2K	﹤0.01%	1004
2018 Q2	$22K	Buy	500 +181	+57%	+$8.67K	﹤0.01%	1072
2018 Q1	$18K	Buy	+319	New	+$17.5K	﹤0.01%	1098

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Benjamin F. Edwards & Company's MD Position: Q4 2019 in Review

Benjamin F. Edwards & Company sold out of Pediatrix Medical (MD) in Q4 2019, closing a stake of 1,773 shares — an estimated $40K sold.

Benjamin F. Edwards & Company first reported a position in MD in Q1 2018 and held it in 7 quarters. The position peaked at $40K in Q3 2019. 258 funds tracked by Wall St. Rank hold MD as of Q4 2019.

Benjamin F. Edwards & Company reported no remaining Pediatrix Medical position as of Q4 2019 after selling out during the quarter.
Benjamin F. Edwards & Company sold 1,773 Pediatrix Medical shares in Q4 2019, an estimated $40K.
Benjamin F. Edwards & Company first reported a position in Pediatrix Medical in Q1 2018 and held it in 7 quarters.
Benjamin F. Edwards & Company's Pediatrix Medical position peaked at $40K in Q3 2019.
258 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2019.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2019, filed 6 Feb 2020.